Screener
Oric Pharmaceuticals, Inc. ORIC Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204047
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating expenses: | ||
| Research and development | $31,437 | $24,640 |
| General and administrative | 8,182 | 8,078 |
| Total operating expenses | 39,619 | 32,718 |
| Loss from operations | (39,619) | (32,718) |
| Other income, net | 3,852 | 2,697 |
| Net loss | $(35,767) | $(30,021) |
| Other comprehensive loss: |
Item 1. Financial Statements.
FAQ
- What is Oric Pharmaceuticals, Inc.'s other operating expenses?
- Oric Pharmaceuticals, Inc. (ORIC) reported other operating expenses of $39.62M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s other operating expenses changed year-over-year?
- Oric Pharmaceuticals, Inc.'s other operating expenses increased by 21.1% year-over-year, from $32.72M to $39.62M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s other operating expenses has grown at a 16.0% compound annual growth rate (CAGR), from $78.87M to $143M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Oric Pharmaceuticals, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude